Brussels, Belgium, November 7, 2014

By assisting BioSourcing ( earlier this summer for its financing round as its exclusive financial advisor, Merodis confirms its strong position in the field of biotech and pharma corporate finance in Belgium.

Joining Bertrand Mérot, CEO and founder of BioSourcing, a series of new shareholders have committed several millions to an investment allowing BioSourcing to develop its first products and demonstrate the significant advantages provided by its unique production platform.

The new shareholders of the company include two private equity funds : Belgian Nausicaa Ventures and French Agipi Innovation, a series of public investors (Meusinvest, Financière Spin-Off Luxembourgeoise, Spinventure and Luxembourg Développement) and several experienced private investors and business angels.

Biosourcing is an emerging player in the production of recombinant protein therapeutics in milk produced by large mammalians for a wide range of veterinary areas. The company enjoys strong partners such as a top tier player in the field of Animal Health, CER Group in Marloie, bringing solid expertise in the fields of biomedical research and the University of Liège.

Bertrand Mérot said: “Together with its partners, BioSourcing is developing innovative medicines, bringing Biologicals to Animal Health area, using an exclusive production platform providing significant competitive advantages compared to the costly cell culture production methods, such as significantly lower capital investment requirement, unmatched scalability and a sizeable cost advantage. Thanks to the commitment of our new shareholders and to the assistance of Merodis, we can now focus on delivering the exciting promises allowed by our breakthrough technology, responding thus, for the first time ever, to the strong demand of Biologicals of the veterinary market”.

For more information, please contact:

Thierry Hazevoets, +32 495 58 68 98
Patrick Michielsen, +32 478 88 58 82
Gerd Philippaerts, +32 488 25 65 23